You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海普瑞(002399.SZ):擬通過子公司參投新元醫療基金II期
格隆匯 10-23 20:43

格隆匯 10 月 23日丨海普瑞(002399.SZ)公佈,為了進一步推進公司產業發展和公司轉型,公司擬通過全資子公司海普瑞(香港)有限公司(“香港海普瑞”)參與投資ORI Capital II Inc. (普通合夥人,“新元資本”)設立的ORI Healthcare Fund II, L.P.(“新元醫療基金II期”)。

公司擬以自有資金4000萬美元對全資子公司香港海普瑞增資,增資資金用於參與設立新元醫療基金II期及支付首期投資款;同時,授權公司管理層審議和批准繼續對香港海普瑞進行增資用於認購新元醫療基金II後續發行的基金份額,後續增資及認購總額不超過首期投資總額。相關法律文件尚未完成簽署,董事會授權香港海普瑞董事李鋰先生簽署,並推動投資完成。

公司通過此次參與投資設立醫療基金,是為了抓住全球醫藥和醫療產業發展的有利時機,充分利用基金管理團隊豐富的產業資源、專業的投資經驗和完善的風險控制體系,及時把握相關產業領域的投資機會,為公司的產業發展儲備和培育優質的潛在項目資源,推動公司業務持續、健康、快速成長。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account